BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32212791)

  • 1. Arg399Gln XRCC1 Polymorphism and Risk of Squamous Cell Carcinoma of the Head and Neck in Jordanian Patients.
    Sobiahe A; Hijazi E; Al-Ameer HJ; Almasri Y; Jarrar Y; Zihlif M; Shomaf M; Al-Rawashdeh B
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):663-665. PubMed ID: 32212791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Arg399Gln single-nucleotide polymorphism in
    Dutta D; Abarna R; Shubham M; Subbiah K; Duraisamy S; Chinnusamy R; Anbalagan M
    J Cancer Res Ther; 2020; 16(3):551-558. PubMed ID: 32719266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S; Wu S; Wang M
    Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
    Kumar A; Pant MC; Singh HS; Khandelwal S
    Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
    Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations.
    Mutlu P; Mutlu M; Yalcin S; Unsoy G; Yaylaci A; Saylam G; Akin I; Korkmaz H; Gunduz U
    J BUON; 2015; 20(2):540-7. PubMed ID: 26011347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
    Noureddini M; Mobasseri N; Karimian M; Behjati M; Nikzad H
    J Gene Med; 2018 Oct; 20(10-11):e3053. PubMed ID: 30160806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck.
    Li C; Hu Z; Lu J; Liu Z; Wang LE; El-Naggar AK; Sturgis EM; Spitz MR; Wei Q
    Cancer; 2007 Aug; 110(4):867-75. PubMed ID: 17614107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
    Wang Y; Chu X; Meng X; Zou F
    PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
    Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
    PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERCC1 C8092A polymorphism predicts fair survival outcome in Japanese patients with pharyngo-laryngeal squamous cell carcinoma.
    Hirakawa H; Ikegami T; Azechi S; Agena S; Uezato J; Kinjyo H; Yamashita Y; Tanaka K; Kondo S; Maeda H; Suzuki M; Gahana A
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):601-610. PubMed ID: 31749055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population.
    Choudhury JH; Choudhury B; Kundu S; Ghosh SK
    Med Oncol; 2014 Aug; 31(8):67. PubMed ID: 24958516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Strong Relationship Between Oral Squamous Cell Carcinoma and DNA Repair Genes.
    Avci H; Ergen A; Bireller ES; Ertugrul B; Cakmakoglu B
    Biochem Genet; 2017 Dec; 55(5-6):378-386. PubMed ID: 28639054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
    Khlifi R; Kallel I; Hammami B; Hamza-Chaffai A; Rebai A
    J Oral Pathol Med; 2014 Mar; 43(3):217-24. PubMed ID: 24020925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck.
    Kowalski M; Przybylowska K; Rusin P; Olszewski J; Morawiec-Sztandera A; Bielecka-Kowalska A; Pietruszewska W; Mlynarski W; Janusz S; Majsterek I
    J Exp Clin Cancer Res; 2009 Mar; 28(1):37. PubMed ID: 19284666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
    Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
    Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
    Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
    DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma.
    Yan L; Yanan D; Donglan S; Na W; Rongmiao Z; Zhifeng C
    Dis Esophagus; 2009; 22(5):396-401. PubMed ID: 19673050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.
    Santonocito C; Scapaticci M; Nedovic B; Annicchiarico EB; Guarino D; Leoncini E; Boccia S; Gasbarrini A; Capoluongo E
    Int J Biol Markers; 2017 May; 32(2):e190-e194. PubMed ID: 28058700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.